Home -
Products -
Chromatin/Epigenetic -
Epigenetic Reader Domain -
SMARCA-BD ligand 1 for Protac dihydrochloride
SMARCA-BD ligand 1 for Protac dihydrochloride
CAS No. 2369053-68-7
SMARCA-BD ligand 1 for Protac dihydrochloride( —— )
Catalog No. M33234 CAS No. 2369053-68-7
SMARCA-BD ligand 1 for Protac dihydrochloride binds to the BAF ATPase subunit SMARCA2 and is used for degrading SMARCA2 based on PROTAC.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 84 | In Stock |
|
| 10MG | 136 | In Stock |
|
| 25MG | 226 | In Stock |
|
| 50MG | 317 | In Stock |
|
| 100MG | 434 | In Stock |
|
| 200MG | 602 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSMARCA-BD ligand 1 for Protac dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionSMARCA-BD ligand 1 for Protac dihydrochloride binds to the BAF ATPase subunit SMARCA2 and is used for degrading SMARCA2 based on PROTAC.
-
DescriptionSMARCA-BD ligand 1 for Protac dihydrochloride is a compound that binds to the BAF ATPase subunits SMARCA2, and used for degrading SMARCA2, based on PROTAC.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorEpigenetic Reader Domain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2369053-68-7
-
Formula Weight344.24
-
Molecular FormulaC14H19Cl2N5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 2.7 mg/mL (7.84 mM; Ultrasonic (<60°C)
-
SMILESCl.Cl.Nc1nnc(cc1N1CCNCC1)-c1ccccc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Farnaby W, et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat Chem Biol. 2019 Jul;15(7):672-680.?
molnova catalog
related products
-
JWG-071
JWG-071, the first reported chemical probe for ERK5 kinase selectivity, is a BET-selective inhibitor with a 1 μM BRD4 IC that enhances both ERK5 activity and BRD4 selectivity.
-
GSK046
GSK046 is a potent, selective and orally active BD2 bromodomain inhibitor of the BET proteins(IC50s of 264 nM (BRD2 BD2), 98 nM (BRD3 BD2), 49 nM (BRD4 BD2) and 214 nM (BRDT BD2), respectively).
-
CBP-IN-1
CBP-IN-1 is a potent inhibitor of p300/CBP bromodomain.
Cart
sales@molnova.com